Skip to main content
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

OmniAb, Inc. - Common Stock (NQ: OABI )

4.780 -0.040 (-0.83%)
Streaming Delayed Price Updated: 4:00 PM EDT, Apr 17, 2024 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Price and Volume

Detailed Quote
Volume 596,968
Open 4.830
Bid (Size) 4.490 (1)
Ask (Size) 4.900 (2)
Prev. Close 4.820
Today's Range 4.735 - 4.860
52wk Range 3.140 - 6.715
Shares Outstanding N/A
Dividend Yield N/A
Chart for (: )
Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

Top News

More News
Over $1M Bet On OmniAb? Check Out These 3 Stocks Insiders Are Buying
Although U.S. stocks closed lower on Monday, there were a few notable insider trades. 
Via Benzinga
OABI Stock Earnings: OmniAb Beats EPS, Misses Revenue for Q4 2023
OABI stock results show that OmniAb beat analyst estimates for earnings per share but missed on revenue for the fourth quarter of 2023. 
Via InvestorPlace

Performance

YTD
-23.52%
-23.52%
1 Month
-7.72%
-7.72%
3 Month
-21.25%
-21.25%
6 Month
-4.21%
-4.21%
1 Year
+36.57%
+36.57%

More News

Read More
Recap: OmniAb Q4 Earnings
Via Benzinga
OmniAb Reports Fourth Quarter and Full Year 2023 Financial Results and Business Highlights
From OmniAb, Inc.
Via Business Wire
Earnings Scheduled For March 20, 2024
Via Benzinga
Earnings Preview For OmniAb
Via Benzinga
OmniAb to Report Fourth Quarter 2023 Financial Results on March 20
From OmniAb, Inc.
Via Business Wire
OmniAb to Participate in Two Investor Conferences in March
From OmniAb, Inc.
Via Business Wire
Mighty Minis: 7 Small-Cap Stocks That Punch Above Their Weight
Via InvestorPlace
OmniAb Presents New Scientific Data on its OmnidAb™ Platform at the 2023 Antibody Engineering & Therapeutics Conference
From OmniAb, Inc.
Via Business Wire
OmniAb Highlights OmnidAb™ Launch and its Expanding Drug Discovery Platform at Today’s Research & Technology Virtual Event
From OmniAb, Inc.
Via Business Wire
OmniAb Reports Third Quarter 2023 Financial Results and Business Highlights
From OmniAb, Inc.
Via Business Wire
OmniAb to Participate in Two Investor Conferences in November
From OmniAb, Inc.
Via Business Wire
OmniAb Appoints Steve Love to its Board of Directors
From OmniAb, Inc.
Via Business Wire
OmniAb Announces Agenda for its Research & Technology Virtual Event
From OmniAb, Inc.
Via Business Wire
7 of the Best Cheap Stocks to Buy Under $5 in October 2023
Via InvestorPlace
OmniAb to Hold Research & Technology Virtual Event on November 9
From OmniAb, Inc.
Via Business Wire
Fisker, Intercept Pharmaceuticals, Immunovant And Other Big Stocks Moving Higher On Tuesday
Via Benzinga
Topics Stocks
Exposures US Equities
OmniAb to Participate in Two Investor Conferences in September
From OmniAb, Inc.
Via Business Wire
OmniAb Reports Second Quarter 2023 Financial Results and Business Highlights
From OmniAb, Inc.
Via Business Wire
OmniAb Announces the Passing of Director Sunil Patel
From OmniAb, Inc.
Via Business Wire
OmniAb to Report Second Quarter 2023 Financial Results on August 10
From OmniAb, Inc.
Via Business Wire
Earnings Scheduled For August 10, 2023
Via Benzinga
7 Stocks to Buy for 200% Returns This Year
Via InvestorPlace
7 Stocks to Buy for Their Massive Upside Potential
Via InvestorPlace
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.